Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain

ClinicalTrials.gov ID: NCT04504812

Public ClinicalTrials.gov record NCT04504812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 4:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT04504812
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Johns Hopkins University
Other
Enrollment
1,937 participants

Conditions and interventions

Interventions

  • Best Practices Other
  • Duloxetine Drug
  • Intra-Articular Injection Combination Product
  • Nerve Procedure with long acting blocks Procedure
  • Nerve Procedure with nerve ablation Procedure
  • Pain Coping Skills Training Behavioral

Other · Drug · Combination Product + 2 more

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2021
Primary completion
Apr 7, 2025
Completion
Apr 7, 2025
Last update posted
Apr 8, 2026

2021 – 2025

United States locations

U.S. sites
24
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
University of California Davis Sacramento California 95817
University of California San Diego San Diego California 92037
VA Medical Center San Diego San Diego California 92161
University of Colorado Aurora Colorado 80045
University of Florida Gainesville Florida 32608
Emory University Atlanta Georgia 30322
Atlanta VA Medical Center Decatur Georgia 30033
Northwestern University Chicago Illinois 60611
University of Iowa Iowa City Iowa 52242
Johns Hopkins Baltimore Maryland 21287
Walter Reed Army Medical Center Bethesda Maryland 20889
Brigham and Women's Hospital Boston Massachusetts 02199
University of Minnesota Minneapolis Minnesota 55455
Weill Cornell University New York New York 10019
University of Rochester Medical Center Rochester New York 14623
University of North Carolina Chapel Hill North Carolina 27599
Wake Forest University Winston-Salem North Carolina 27517
Cleveland VA Medical Center Cleveland Ohio 44106
University Hospitals Cleveland Ohio 44106
Oregon Health and Science University Portland Oregon 97239
Vanderbilt University Nashville Tennessee 37232
University of Utah Salt Lake City Utah 84108
University of Virginia Charlottesville Virginia 22908
University of Washington Seattle Washington 98185

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04504812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 8, 2026 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04504812 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →